Effectiveness of glycopyrronium bromide in the treatment of small airway dysfunction: A retrospective study
Objective: Glycopyrronium bromide has a quaternary ammonium structure and a low oral bioavailability, which reduces its systemic effects; it acts through a bronchodilating blockade of muscarinic receptors. The aim of this retrospective study was to analyze a possible relationship between the changes...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/20503121221145605 |